Production of recombinant human granulocyte‐macrophage colony‐stimulating factor in thermoinducible E. coli : Tuning inclusion body architecture and protein yield via dissolved oxygen control
Journal of Chemical Technology & Biotechnology · 2026-12 · 101 (12) · 2550-2562
DOI: 10.1002/jctb.70257 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Technology & Biotechnology, online erschienen am 12.08.2026. Verfasst von Ximena Gómez‐Gil und 7 weiteren Autor:innen. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND Recombinant protein expression in Escherichia coli frequently results in the formation of inclusion bodies (IBs), which provide high protein accumulation but often require additional steps to recover functional protein. Although culture conditions strongly influence IB physicochemical and structural characteristics, the impact of dissolved oxygen tension (DOT) remains poorly understood in thermoinducible expression systems widely used for industrial production. RESULTS Recombinant human granulocyte‐macrophage colony‐stimulating factor (rHuGM‐CSF) was produced in E. coli using the thermoinducible λpL‐cI857 system. Post‐induction DOT significantly affected recombinant rHuGM‐CSF production, size, and structural properties of IBs. Cultures maintained at low DOT (5–10%) showed the highest volumetric and specific protein production, despite lower specific growth rates compared to cultures at 30% and 70% DOT. Low DOT also produced larger IBs, with reduced amyloid‐like content and higher susceptibility to proteolytic degradation and partial solubilization, indicating a less compact aggregate structure. In contrast, higher DOT (30–70%) favored faster early post‐induction accumulation but resulted in smaller, more rigid IBs with increased resistance to solubilization and proteolysis. CONCLUSION Post‐induction DOT is an effective process parameter for modulating IB morphology, aggregation state, and recombinant protein yields, providing practical strategy to improve recombinant protein downstream recovery in thermoinducible E. coli bioprocesses. © 2026 The Author(s). Journal of Chemical Technology and Biotechnology published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry (SCI).
Zitieren
APA
Gómez‐Gil, X., Valdez‐Cruz, N. A., Restrepo‐Pineda, S., Sánchez‐Puig, N., Vázquez‐Duhalt, R., Cadena‐Nava, R. D., Pérez, N. O., & Trujillo‐Roldán, M. A. (2026). Production of recombinant human granulocyte‐macrophage colony‐stimulating factor in thermoinducible E. coli : Tuning inclusion body architecture and protein yield via dissolved oxygen control. Journal of Chemical Technology & Biotechnology, 101(12), 2550-2562. https://doi.org/10.1002/jctb.70257
Vancouver
Gómez‐Gil X, Valdez‐Cruz NA, Restrepo‐Pineda S, Sánchez‐Puig N, Vázquez‐Duhalt R, Cadena‐Nava RD, et al. Production of recombinant human granulocyte‐macrophage colony‐stimulating factor in thermoinducible E. coli : Tuning inclusion body architecture and protein yield via dissolved oxygen control. Journal of Chemical Technology & Biotechnology. 2026;101(12):2550-2562. doi:10.1002/jctb.70257
BibTeX
@article{GmezGil2026,
author = {Gómez‐Gil, Ximena and Valdez‐Cruz, Norma A and Restrepo‐Pineda, Sara and Sánchez‐Puig, Nuria and Vázquez‐Duhalt, Rafael and Cadena‐Nava, Rubén D and Pérez, Néstor O and Trujillo‐Roldán, Mauricio A},
title = {Production of recombinant human granulocyte‐macrophage colony‐stimulating factor in thermoinducible E. coli : Tuning inclusion body architecture and protein yield via dissolved oxygen control},
journal = {Journal of Chemical Technology & Biotechnology},
year = {2026},
volume = {101},
number = {12},
pages = {2550--2562},
doi = {10.1002/jctb.70257}
}
EUVIMED